OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 02, 2011
Inside the National Institutes of Health
Developing a quality agreement template for single-use systems.
Market considerations and new technologies must be recognized to achieve the full benefits of manufacturing prefilled syringes.
An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.
The lower price of biosimilars will increase patient access to medicines and spur innovation.
The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.
September 01, 2011
Biopharmaceutical Trends Report